References
- Money K E. Motion sickness. Physiol Rev 1970; 50: 1–39
- Wilpizeski C R, Lowry L D, Miller R A, Smith B D, Goldman W S. Adaptation and habituation of motion-induced vomiting in squirrel monkeys. Aviat Space Environ Med 1987; 58((Suppl 9))A22-8
- Wood C D, Manno J E, Manno B R, Odenheimer R C, Bairnsfather L E. The effect of antimotion sickness drugs on habituation to motion. Aviat Space Environ Med 1986; 57: 539–42
- Graybiel A, Lackner J R. Motion sickness: acquisition and retention of adaptation effects compared in three motion environments. Aviat Space Environ Med 1983; 54: 307–11
- Wilpizeski C R, Lowry L D, Green S J, Smith B D, Melnick H. Subjective concomitants of motion sickness: quantifying rotation-induced illness in squirrel monkeys. Otolaryngol Head Neck Surg 1987; 97: 433–40
- Mitchell D, Laycok J D, Stephens W F. Motion induced pica in rats. J Clin Nutr 1977; 30: 147–50
- McCaffrey R J. Appropriateness of kaolin consumption as an index of motion sickness in the rat. Physiol Behav 1985; 35: 151–6
- Morita M, Takeda N, Kubo T, Matsunaga T. Pica as an index of motion sickness in rats. ORL 1988; 50: 188–92
- Morita M, Takeda N, Kubo T, Yamatodani A, Wada H, Matsunaga T. Effects of anti-motion sickness drugs on motion sickness in rats. ORL 1988; 50: 330–3
- Clissold S P, Heel R C. Transdermal hyoscine (scopolamine): a preliminary review of its pharmacodynamic properties and therapeutic efficacy. Drugs 1985; 29: 189–207
- Wilpizeski C R, Lowry L D. A two-factor model of rotation-induced motion sickness syndrome in squirrel monkeys. Am J Otolaryngol 1987; 8: 7–12
- Wilpizeski C R, Lowry L D, Eyyunni U, Raheb M E, Goldman W S. Behavioral conditioning and experimental motion-induced sickness. Am J Otolaryngol 1985; 6: 258–63
- Janowsky D S, Risch S C, Zeigler M, Kennedy B, Huey L. A cholinomimetic model of motion sickness and space adaptation syndrome. Aviat Space Environ Med 1984; 55: 692–6
- Kohl R L, Ryan P, Homick J L. Efficacy of phosphatidylcholine in the modulation of motion sickness susceptibility. Aviat Space Environ Med 1985; 56: 125–8
- Wecker L, Schmidt D E. Central cholinergic function: relationship to choline administration. Life Sci 1979; 25: 375–84
- Kohl R L. Sensory conflict theory of space motion sickness: an anatomical location for the neuroconflict. Aviat Space Environ Med 1983; 54: 464–5
- Ito J, Matsuoka I, Sasa M, Fujimoto S, Takaori S. Electrophysiologic evidence for involvement of acetylcholine as neurotransmitter in the lateral vestibular nucleus. Otolaryngol Head Neck Surg 1981; 89: 1025–9
- Wamsley J K, Lewis M S, Young W S, III, Kuhar M J. Autoradiographic localization of muscarinic cholinergic receptors in rat brain stem. J Neurosci 1981; 1: 176–91
- Kohl R L, Homick J L. Motion sickness: a modulatory role for the central cholinergic nervous system. Neurosci Biobehav Rev 1983; 7: 73–85
- Benson A J. Motion sickness. Vertigo, M R Dix, J D Hood. Wiley & Sons, London 1984; 391–426
- Sitaram N, Weingartner H, Gillin J C. Human serial learning: enhancement with arecoline and impairment with scopolamine. Science 1978; 201: 274–6
- Bratti C M, Huygens P, Mino J, Merlo A, Gardella J, Jr. Memory facilitation with post-trial injection of oxotremorine and physostigmine in mice. Psychopharmacology 1979; 64: 85–8
- Takeda N, Morita M, Kubo T, et al. Histaminergic mechanisms of motion sickness: neurochemical and neuropharmacological studies in rats. Acta Otolaryngol (Stockh) 1986; 101: 416–21
- Takeda N, Morita M, Kubo T, Yamatodani A, Wada H, Matsunaga T. Is the noradrenergic neuron system in the brain stem related to motion sickness in rats?. Adv Otorhinolaryngol 1988; 42: 234–7
- Takeda N, Morita M, Hasegawa S, Kubo T, Matsunaga T. Neurochemical mechanisms of motion sickness. Am J Otolaryngol 1989; 10: 351–9